Entity
Description
  • Value proposition

    Industrializing scientific discovery to radically improve lives.


    Valence Labs, powered by Recursion, is industrializing scientific discovery to radically improve lives. Our vision is that highly autonomous systems capable of Nobel-worthy insights will usher in a new wave of scientific discovery.

    Following the acquisition of Valence Discovery by Recursion (NASDAQ: RXRX) in May 2023, Valence Labs continues as a semi-autonomous AI research engine within Recursion aiming to advance the frontier of deep learning in drug discovery. Valence Labs operates with the unique combination of the intellectual freedom of academia but the resources and stability of industry.

    Valence Labs is headquartered in Montreal at Mila, the world's largest deep learning research institute, and supported by AI pioneers such as Yoshua Bengio.

  • Valence Labs | Advancing AI for Drug Discovery

    Valence Labs, powered by Recursion, is a research engine harnessing computation to radically improve lives.

  • https://www.valencelabs.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Pfizer
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Partnership
Event

21 Nov 2018


Techstars Iowa Accelerator
Techstars Iowa Accelerator
Startup accelerator & VC, Venture Capital & Private Equity
Techstars Iowa Accelerator
Startup accelerator & VC, Venture Capital & Private Equity
Not capitalistic
Not partnership
Event

29 Mar 2021


Similar entities
Loading...
Loading...
Social network dynamics